FDA Inspection 1027889 — Department Of Defense - Naval Hospital Camp Pendleton

Department Of Defense - Naval Hospital Camp Pendleton — FEI 2076574

The FDA completed an inspection of Department Of Defense - Naval Hospital Camp Pendleton on Sep 18, 2017 in Camp Pendleton, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Camp Pendleton, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.